EW
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| A population pharmacokinetic model for escitalopram and its major metabolite in depressive patients during the perinatal period: Prediction of infant drug exposure through breast milk | British Journal of Clinical Pharmacology |  | 2020 | 442 | 2 | ||
| Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence - an update | Expert Opinion on Drug Safety | | 2019 | 280 | 0 | ||
| Evaluation of drug exposure and safety during pregnancy and lactation | | 2016 | 712 | 5 | |||
| Bon usage des antidépresseurs ISRS durant la grossesse – le défi de l'évaluation de la balance bénéfice-risque | Revue médicale suisse | | 2016 | 691 | 5 |
